To The Moon

$Precigen(PGEN)$ It's been almost a year since I last posted about this ticker back then in August 2025; https://tigr.link/s/30HSadE. Back then, stock was trading at about $2.60. 11 months have past. We see that PGEN has shifted significantly from a pre-commercial speculative biotech company to a validated commercial stage one. Primary driver for this important milestone is the launch of PAPZIMEOS, its gene therapy for recurrent respiratory papillomatosis in adults. In 2026Q1, this has generated $21.6M in net product revenue ( massive jump from $3.4M in 2025Q4 ). Total revenue has reached $23.25M, beating expectations of $20M. With their optimistic target to achieve cash flow break even by end of this year, 2026Q1 operating loss has narrowed down

$Singtel(Z74.SI)$   I last talk about this counter was back in 2023, it’s been months and market conditions + SingTel prices have changed however my position remains the same. Last closing price on 12 July was $2.95. The last time we saw this price was in 2020 March pandemic. SingTel prices was on the downtrend. $2.95 wasn’t even support price because $2.95 was not only broken easily but price dive further down the months. Right now, $2.95 became the resistance price instead, having tested on 11 & 12 July. Since Jun 2024 with SingTel joint venture into developing next gen data centre in Msia, the upward trend got steeper. With the sell down of Airtel , capital recycling to unlock value from its assets and partnering with lend

$SanDisk Corp.(SNDK)$  The Head and Shoulders pattern already formed - > The beginning of the downtrend  4 important components of the H&S pattern: (1) Left Shoulder (peak around mid-June), (2) the Head (the highest peak around late June/early July and the (3) Right Shoulder , the lower peak in mid-July. The most critical part of this pattern is No.4 which is the neckline which I have indicated with the blue line (the support level connecting the lows between the shoulders, roughly around the 1500 -1600 level.  The current price of 1210 ( pre-mkt )  has decisively broken below this neckline ( Sellers taking control even before market open ). This confirms the H&S pattern is completed and validate

$HSI(HSI)$  Price is on a short-term uptrend and is currently trading above both the 20 MA (orange line, at ~24,373) and the 50 MA (yellow curvy line at ~24,588). After bottoming out in late June, the market staged a sharp impulse recovery. Reclaiming both the 20 MA and 50 MA confirms that near-term momentum has shifted back to the bulls. Furthermore, the 20 MA crossing back above the 50 MA indicates short-term bullish acceleration. RSI at 60, There is still room for the index to push higher before becoming technically exhausted after RSI 70. With the clear uptrend yellow straight line that i drawn, not the wavy curvy one, long as price respects this yellow boundary on pullbacks, the path of least resistance

$SanDisk Corp.(SNDK)$  1. The Moving Average Crossover  The 20MA ($1,683.63) has crossed below the 50MA ($1,727.02) While this is a short-to-medium-term bearish crossover, lets wait for a true classical Death Cross when the 50MA crosses below the 200MA. The 50MA ($1,727.02) is still significantly higher than the 200MA. The broader macro uptrend remains intact structural-wise, but short-term momentum is firmly in control of the bears. 2. Descending Channel & Price Action Channel Support: I have drawn the yellow parallel lines which map out the downward channel formed since the peak near $2,300+. With the current price around $1,268, continuing to ride the lower boundary of this channel could easily push the stock below $1,000. If

$HSI(HSI)$  Inverse Head & Shoulder Pattern In the Making -> Potential Reversal Coming 1. The Left Shoulder (Mid-June) Around early June, the HSI experienced a downward move that found temporary support (roughly around the 24,400 level) before a minor, short-lived bounce 2. The Head (Late June) Following that minor bounce, a steeper sell-off began mid-month, culminating in a major swing low in late June at approximately 22,600. This capitulation was met with a sharp, aggressive V-shaped rally back upward through early July, which forms the deep center trough 3. The Neckline (Mid-July) The rally peaked in mid-July right around the 25,166 level This area lined up with the descending 50-day Moving Average (yellow

Great article, would you like to share it?

Great article, would you like to share it?

$Richtech Robotics(RR)$  

$Precigen(PGEN)$ Finally some good news for this stock. Precigen, Inc. (PGEN) said on Friday that the US Food and Drug Administration (FDA) has approved its immunotherapy Papzimeos for the treatment of adults with recurrent respiratory papillomatosis (RRP). Recurrent respiratory papillomatosis (RRP) is a rare condition where benign, wart-like tumors, called papillomas, grow in the respiratory tract, most commonly the larynx or the voice box. The disease can lead to severe voice disturbance, a compromised airway, and recurrent post-obstructive pneumonias. According to Precigen, there are about 27,000 adult RRP patients in the U.S and Papzimeos is now the first and only FDA-approved therapy for the treatment of adults with RRP.

$TSLA 20250815 290.0 PUT$ 

$SoFi Technologies Inc.(SOFI)$